{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T20:55:06Z","timestamp":1791060906503,"version":"4.1.0"},"reference-count":73,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82272975"],"award-info":[{"award-number":["82272975"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82273238"],"award-info":[{"award-number":["82273238"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005230","name":"Natural Science Foundation of Chongqing Municipality","doi-asserted-by":"publisher","award":["CSTB2024NSCQ-MSX0193"],"award-info":[{"award-number":["CSTB2024NSCQ-MSX0193"]}],"id":[{"id":"10.13039\/501100005230","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004374","name":"Chongqing Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004374","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017501","name":"Science-Health Joint Medical Scientific Research Project of Chongqing","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017501","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.bbadis.2026.168179","type":"journal-article","created":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T01:53:40Z","timestamp":1770170020000},"page":"168179","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Glucosamine suppresses hepatocellular carcinoma progression through dual inhibition of cell cycle progression and nucleotide metabolism"],"prefix":"10.1016","volume":"1872","author":[{"given":"Yan-lai","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-xin","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"De-ao","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu-yi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ni","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbadis.2026.168179_bb0005","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.bbadis.2026.168179_bb0010","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/s41571-023-00825-3","article-title":"Global trends in hepatocellular carcinoma epidemiology: implications for screening, prevention and therapy","volume":"20","author":"Singal","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.bbadis.2026.168179_bb0015","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/s41575-022-00704-9","article-title":"Evolving therapeutic landscape of advanced hepatocellular carcinoma","volume":"20","author":"Yang","year":"2023","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bbadis.2026.168179_bb0020","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.ccell.2024.01.007","article-title":"Precision treatment in advanced hepatocellular carcinoma","volume":"42","author":"Yang","year":"2024","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbadis.2026.168179_bb0025","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/S0140-6736(22)01200-4","article-title":"Hepatocellular carcinoma","volume":"400","author":"Vogel","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.bbadis.2026.168179_bb0030","article-title":"Hepatocellular carcinoma recurrence after liver transplantation: risk factors, targeted surveillance and management options","volume":"10","author":"Pelizzaro","year":"2024","journal-title":"Hepatoma Res."},{"key":"10.1016\/j.bbadis.2026.168179_bb0035","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1056\/NEJM198905183202006","article-title":"The biology of osteoarthritis","volume":"320","author":"Hamerman","year":"1989","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbadis.2026.168179_bb0040","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.jbspin.2020.09.004","article-title":"Recommendations of the French Society of Rheumatology on pharmacological treatment of knee osteoarthritis","volume":"87","author":"Sellam","year":"2020","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.bbadis.2026.168179_bb0045","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.ijbiomac.2019.03.234","article-title":"Chondroprotective action of glucosamine, a chitosan monomer, on the joint health of athletes","volume":"132","author":"Nagaoka","year":"2019","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.bbadis.2026.168179_bb0050","doi-asserted-by":"crossref","first-page":"3694","DOI":"10.3390\/nu14183694","article-title":"Glucosamine use is associated with a higher risk of cardiovascular diseases in patients with osteoarthritis: results from a large study in 685,778 subjects","volume":"14","author":"Yu","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.bbadis.2026.168179_bb0055","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0041540","article-title":"Who uses glucosamine and why? A study of 266,848 Australians aged 45 years and older","volume":"7","author":"Sibbritt","year":"2012","journal-title":"PloS One"},{"issue":"Suppl A","key":"10.1016\/j.bbadis.2026.168179_bb0060","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S1063-4584(98)80006-X","article-title":"Anti-inflammatory activity of chondroitin sulfate","volume":"6","author":"Ronca","year":"1998","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.bbadis.2026.168179_bb0065","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1093\/aje\/kws186","article-title":"Association between use of specialty dietary supplements and C-reactive protein concentrations","volume":"176","author":"Kantor","year":"2012","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.bbadis.2026.168179_bb0070","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.etap.2014.05.018","article-title":"Protective effects of glucosamine hydrochloride against free radical-induced erythrocytes damage","volume":"38","author":"Jamialahmadi","year":"2014","journal-title":"Environ. Toxicol. Pharmacol."},{"key":"10.1016\/j.bbadis.2026.168179_bb0075","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.freeradbiomed.2014.01.026","article-title":"Glucosamine attenuates cigarette smoke-induced lung inflammation by inhibiting ROS-sensitive inflammatory signaling","volume":"69","author":"Wu","year":"2014","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bbadis.2026.168179_bb0080","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.762","article-title":"Glucosamine facilitates cardiac ischemic recovery via recruiting Ly6Clow monocytes in a STAT1 and O-GlcNAcylation-dependent fashion","volume":"12","author":"Zhou","year":"2022","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.bbadis.2026.168179_bb0085","doi-asserted-by":"crossref","first-page":"H268","DOI":"10.1152\/ajpheart.00142.2009","article-title":"Effect of a high dose of glucosamine on systemic and tissue inflammation in an experimental model of atherosclerosis aggravated by chronic arthritis","volume":"297","author":"Largo","year":"2009","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.bbadis.2026.168179_bb0090","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.freeradbiomed.2016.12.032","article-title":"Augmented O-GlcNAc signaling via glucosamine attenuates oxidative stress and apoptosis following contrast-induced acute kidney injury in rats","volume":"103","author":"Hu","year":"2017","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bbadis.2026.168179_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.crfs.2024.100699","article-title":"Glucosamine attenuates alcohol-induced acute liver injury via inhibiting oxidative stress and inflammation","volume":"8","author":"Lai","year":"2024","journal-title":"Curr. Res. Food Sci."},{"key":"10.1016\/j.bbadis.2026.168179_bb0100","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.clnu.2025.02.012","article-title":"Glucosamine supplementation attenuates progression of metabolic dysfunction-associated steatotic liver disease and related comorbidities","volume":"47","author":"Ryu","year":"2025","journal-title":"Clin. Nutr."},{"key":"10.1016\/j.bbadis.2026.168179_bb0105","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1136\/annrheumdis-2020-217176","article-title":"Associations of regular glucosamine use with all-cause and cause-specific mortality: a large prospective cohort study","volume":"79","author":"Li","year":"2020","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.bbadis.2026.168179_bb0110","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/171252a0","article-title":"Inhibition of tumour growth by D-glucosamine","volume":"171","author":"Quastel","year":"1953","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2026.168179_bb0115","doi-asserted-by":"crossref","first-page":"487","DOI":"10.3858\/emm.2011.43.9.055","article-title":"Glucosamine induces cell death via proteasome inhibition in human ALVA41 prostate cancer cell","volume":"43","author":"Liu","year":"2011","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.bbadis.2026.168179_bb0120","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.3892\/ijo.2014.2336","article-title":"Short-term treatment with glucosamine hydrochloride specifically downregulates hypoxia-inducible factor-1\u03b1 at the protein level in YD-8 human tongue cancer cells","volume":"44","author":"Jo","year":"2014","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.bbadis.2026.168179_bb0125","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1002\/jcp.24955","article-title":"Inhibition of PKC-induced COX-2 and IL-8 expression in human breast cancer cells by glucosamine","volume":"230","author":"Chou","year":"2015","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.bbadis.2026.168179_bb0130","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.canlet.2008.08.015","article-title":"Glucosamine is an effective chemo-sensitizer via transglutaminase 2 inhibition","volume":"273","author":"Kim","year":"2009","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbadis.2026.168179_bb0135","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1002\/ijc.30250","article-title":"Use of glucosamine and chondroitin supplements in relation to risk of colorectal cancer: results from the Nurses\u2019 Health Study and Health Professionals follow-up study","volume":"139","author":"Kantor","year":"2016","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbadis.2026.168179_bb0140","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01399-2021","article-title":"Relationship between glucosamine use and the risk of lung cancer: data from a nationwide prospective cohort study","volume":"59","author":"Li","year":"2022","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.bbadis.2026.168179_bb0145","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1002\/hep.24736","article-title":"AKT and N-Ras co-activation in the mouse liver promotes rapid carcinogenesis via mTORC1, FOXM1\/SKP2, and c-Myc pathways","volume":"55","author":"Ho","year":"2012","journal-title":"Hepatol. Baltim. Md."},{"key":"10.1016\/j.bbadis.2026.168179_bb0150","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.joca.2005.07.009","article-title":"Glucosamine oral bioavailability and plasma pharmacokinetics after increasing doses of crystalline glucosamine sulfate in man","volume":"13","author":"Persiani","year":"2005","journal-title":"Osteoarthr. Cartil."},{"key":"10.1016\/j.bbadis.2026.168179_bb0155","doi-asserted-by":"crossref","first-page":"W212","DOI":"10.1093\/nar\/gkz446","article-title":"ChEA3: transcription factor enrichment analysis by orthogonal omics integration","volume":"47","author":"Keenan","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbadis.2026.168179_bb0160","doi-asserted-by":"crossref","first-page":"D174","DOI":"10.1093\/nar\/gkad1059","article-title":"JASPAR 2024: 20th anniversary of the open-access database of transcription factor binding profiles","volume":"52","author":"Rauluseviciute","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbadis.2026.168179_bb0165","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a040592","article-title":"Nucleotide metabolism","volume":"13","author":"Chandel","year":"2021","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.bbadis.2026.168179_bb0170","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.1093\/bioinformatics\/btw230","article-title":"Combenefit: an interactive platform for the analysis and visualization of drug combinations","volume":"32","author":"Di Veroli","year":"2016","journal-title":"Bioinforma. Oxf. Engl."},{"key":"10.1016\/j.bbadis.2026.168179_bb0175","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/S0140-6736(18)30207-1","article-title":"Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial","volume":"391","author":"Kudo","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.bbadis.2026.168179_bb0180","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S2468-1253(21)00110-2","article-title":"Lenvatinib versus sorafenib for first-line treatment of unresectable hepatocellular carcinoma: patient-reported outcomes from a randomised, open-label, non-inferiority, phase 3 trial","volume":"6","author":"Vogel","year":"2021","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"10.1016\/j.bbadis.2026.168179_bb0185","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s13045-024-01647-1","article-title":"Lenvatinib and immune-checkpoint inhibitors in hepatocellular carcinoma: mechanistic insights, clinical efficacy, and future perspectives","volume":"17","author":"Chen","year":"2024","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.bbadis.2026.168179_bb0190","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/s12943-019-1086-z","article-title":"The emerging role of microRNAs and long noncoding RNAs in drug resistance of hepatocellular carcinoma","volume":"18","author":"Wei","year":"2019","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bbadis.2026.168179_bb0195","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.3748\/wjg.v8.i6.1029","article-title":"Mechanism of 5-fluorouracil required resistance in human hepatocellular carcinoma cell line Bel7402","volume":"8","author":"Jin","year":"2002","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.bbadis.2026.168179_bb0200","doi-asserted-by":"crossref","first-page":"7883","DOI":"10.1007\/s00253-019-10084-x","article-title":"Categories and biomanufacturing methods of glucosamine","volume":"103","author":"Ma","year":"2019","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.bbadis.2026.168179_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmr.2024.100030","article-title":"Cell cycle dysregulation in cancer","volume":"77","author":"Glaviano","year":"2025","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.bbadis.2026.168179_bb0210","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.tcb.2021.07.001","article-title":"Cell cycle on the crossroad of tumorigenesis and cancer therapy","volume":"32","author":"Liu","year":"2022","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.bbadis.2026.168179_bb0215","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.ccell.2021.03.010","article-title":"Targeting cell-cycle machinery in cancer","volume":"39","author":"Suski","year":"2021","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbadis.2026.168179_bb0220","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1091\/mbc.02-02-0030","article-title":"Identification of genes periodically expressed in the human cell cycle and their expression in tumors","volume":"13","author":"Whitfield","year":"2002","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.bbadis.2026.168179_bb0225","doi-asserted-by":"crossref","first-page":"6070","DOI":"10.1093\/nar\/gkw523","article-title":"Integration of TP53, DREAM, MMB-FOXM1 and RB-E2F target gene analyses identifies cell cycle gene regulatory networks","volume":"44","author":"Fischer","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbadis.2026.168179_bb0230","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.tibs.2022.06.007","article-title":"Coordinating gene expression during the cell cycle","volume":"47","author":"Fischer","year":"2022","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.bbadis.2026.168179_bb0235","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/nrc2696","article-title":"Emerging roles of E2Fs in cancer: an exit from cell cycle control","volume":"9","author":"Chen","year":"2009","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbadis.2026.168179_bb0240","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.tcb.2008.08.003","article-title":"E2F - at the crossroads of life and death","volume":"18","author":"Polager","year":"2008","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.bbadis.2026.168179_bb0245","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.molmed.2012.10.009","article-title":"E2F1 apoptosis counterattacked: evil strikes back","volume":"19","author":"P\u00fctzer","year":"2013","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.bbadis.2026.168179_bb0250","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1158\/0008-5472.CAN-11-2575","article-title":"The dark side of E2F1: in transit beyond apoptosis","volume":"72","author":"Engelmann","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbadis.2026.168179_bb0255","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1475-2867-9-25","article-title":"Glucosamine suppresses proliferation of human prostate carcinoma DU145 cells through inhibition of STAT3 signaling","volume":"9","author":"Chesnokov","year":"2009","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.bbadis.2026.168179_bb0260","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s12894-017-0221-7","article-title":"Anti-proliferative potential of glucosamine in renal cancer cells via inducing cell cycle arrest at G0\/G1 phase","volume":"17","author":"Wang","year":"2017","journal-title":"BMC Urol."},{"key":"10.1016\/j.bbadis.2026.168179_bb0265","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0014-5793(02)03058-2","article-title":"GLUT2 is a high affinity glucosamine transporter","volume":"524","author":"Uldry","year":"2002","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbadis.2026.168179_bb0270","doi-asserted-by":"crossref","DOI":"10.1038\/srep28452","article-title":"Embryonic stem cell proliferation stimulated by altered anabolic metabolism from glucose transporter 2-transported glucosamine","volume":"6","author":"Jung","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbadis.2026.168179_bb0275","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3892\/or.2025.8906","article-title":"Glucose transporter 2-transported glucosamine inhibits glycolysis in cancer cell lines through competition with glucose for hexokinase II","volume":"53","author":"Park","year":"2025","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.bbadis.2026.168179_bb0280","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.fct.2004.11.006","article-title":"Glucosamine effects in humans: a review of effects on glucose metabolism, side effects, safety considerations and efficacy","volume":"43","author":"Anderson","year":"2005","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.bbadis.2026.168179_bb0285","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1007\/s001250051599","article-title":"Presence of glutamine:fructose-6-phosphate amidotransferase for glucosamine-6-phosphate synthesis in endothelial cells: effects of hyperglycaemia and glutamine","volume":"44","author":"Wu","year":"2001","journal-title":"Diabetologia"},{"key":"10.1016\/j.bbadis.2026.168179_bb0290","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1432-1033.1982.tb05811.x","article-title":"Uridylate trapping induced by the C-2-modified D-glucose analogs glucosone, fluoroglucose, and glucosamine","volume":"121","author":"Holstege","year":"1982","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.bbadis.2026.168179_bb0295","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/BFb0027661","article-title":"Galactosamine hepatitis: key role of the nucleotide deficiency period in the pathogenesis of cell injury and cell death","author":"Decker","year":"1974","journal-title":"Rev. Physiol. Biochem. Pharmacol."},{"key":"10.1016\/j.bbadis.2026.168179_bb0300","first-page":"1068","article-title":"The inhibition of thymidine kinase in glial tumor cells by an amino sugar, D-glucosamine","volume":"37","author":"Friedman","year":"1977","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbadis.2026.168179_bb0305","first-page":"482","article-title":"Transport and metabolism of glucosamine by cultured Novikoff rat hepatoma cells and effects on nucleotide pools","volume":"33","author":"Plagemann","year":"1973","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbadis.2026.168179_bb0310","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.joca.2009.03.004","article-title":"Differential metabolic effects of glucosamine and N-acetylglucosamine in human articular chondrocytes","volume":"17","author":"Shikhman","year":"2009","journal-title":"Osteoarthr. Cartil. OARS Osteoarthr. Res. Soc."},{"key":"10.1016\/j.bbadis.2026.168179_bb0315","first-page":"699","article-title":"Absorption, distribution, metabolism and excretion of glucosamine sulfate. A review","volume":"51","author":"Setnikar","year":"2001","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.bbadis.2026.168179_bb0320","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1002\/jps.23819","article-title":"Glucosamine dose\/concentration-effect correlation in the rat with adjuvant arthritis","volume":"103","author":"Aghazadeh-Habashi","year":"2014","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.bbadis.2026.168179_bb0325","doi-asserted-by":"crossref","first-page":"2574","DOI":"10.1002\/jps.23145","article-title":"Absorption and bioavailability of glucosamine in the rat","volume":"101","author":"Ibrahim","year":"2012","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.bbadis.2026.168179_bb0330","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.joca.2005.07.009","article-title":"Glucosamine oral bioavailability and plasma pharmacokinetics after increasing doses of crystalline glucosamine sulfate in man","volume":"13","author":"Persiani","year":"2005","journal-title":"Osteoarthr. Cartil."},{"key":"10.1016\/j.bbadis.2026.168179_bb0335","first-page":"264","article-title":"The glucosamine controversy; a pharmacokinetic issue","volume":"14","author":"Aghazadeh-Habashi","year":"2011","journal-title":"J. Pharm. Pharm. Sci. Publ. Can. Soc. Pharm. Sci. Soc. Can. Sci. Pharm."},{"key":"10.1016\/j.bbadis.2026.168179_bb0340","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1208\/s12249-017-0787-0","article-title":"In vivo anticancer efficacy and toxicity studies of a novel polymer conjugate N-acetyl glucosamine (NAG)-PEG-doxorubicin for targeted cancer therapy","volume":"18","author":"Pawar","year":"2017","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.bbadis.2026.168179_bb0345","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2020.188391","article-title":"Lenvatinib for hepatocellular carcinoma: from preclinical mechanisms to anti-cancer therapy","volume":"1874","author":"Zhao","year":"2020","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"10.1016\/j.bbadis.2026.168179_bb0350","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s12672-023-00631-4","article-title":"Lenvatinib inhibits intrahepatic cholangiocarcinoma via Gadd45a-mediated cell cycle arrest","volume":"14","author":"Yan","year":"2023","journal-title":"Discov. Oncol."},{"key":"10.1016\/j.bbadis.2026.168179_bb0355","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/s41420-023-01664-y","article-title":"Synergistic antitumor efficacy of aspirin plus lenvatinib in hepatocellular carcinoma via regulating of diverse signaling pathways","volume":"9","author":"Yan","year":"2023","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.bbadis.2026.168179_bb0360","article-title":"Targeting CDK2 confers vulnerability to lenvatinib via driving senescence in anaplastic thyroid cancer","volume":"12","author":"Ma","year":"2024","journal-title":"Adv. Sci."},{"key":"10.1016\/j.bbadis.2026.168179_bb0365","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.mam.2016.11.005","article-title":"Targeting nuclear thymidylate biosynthesis","volume":"53","author":"Chon","year":"2017","journal-title":"Mol. Aspects Med."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092544392600027X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092544392600027X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T20:23:28Z","timestamp":1791059008000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092544392600027X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":73,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S092544392600027X"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2026.168179","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glucosamine suppresses hepatocellular carcinoma progression through dual inhibition of cell cycle progression and nucleotide metabolism","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2026.168179","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"168179"}}